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SUMMARY
SETTING —Tuberculosis (TB) patients and their contacts enrolled in nine states and the District 
of Columbia from 16 December 2009 to 31 March 2011.
OBJECTIVE —To evaluate characteristics of TB patients that are predictive of tuberculous 
infection in their close contacts.
DESIGN —The study population was enrolled from a list of eligible African-American and White 
TB patients from the TB registry at each site. Information about close contacts was abstracted 
from the standard reports of each site.
RESULTS —Close contacts of African-American TB patients had twice the risk of infection of 
contacts of White patients (adjusted risk ratio [aRR] 2.1, 95%CI 1.3–3.4). Close contacts of 
patients whose sputum was positive for acid-fast bacilli on sputum smear microscopy had 1.6 
times the risk of tuberculous infection compared to contacts of smear-negative patients (95%CI 
1.1–2.3). TB patients with longer (>3 months) estimated times to diagnosis did not have higher 
proportions of infected contacts (aRR 1.2, 95%CI 0.9–1.6).
CONCLUSION —African-American race and sputum smear positivity were predictive of 
tuberculous infection in close contacts. This study did not support previous findings that longer 
estimated time to diagnosis predicted tuberculous infection in contacts.
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TUBERCULOSIS (TB) control programs need to know which TB patient characteristics 
best predict transmission in order to allocate limited resources to screening of contacts most 
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at risk for latent tuberculous infection (LTBI) and disease progression.1,2 Previously 
identified predictors of transmission include longer times from symptom onset to TB 
diagnosis, presence of acid-fast bacilli (AFB) in sputum smears, and pulmonary cavities on 
chest radiography.3–6
We hypothesized that TB cases with delayed diagnosis, defined as a longer time from 
symptom onset to TB diagnosis, would be more likely to transmit TB to their contacts. We 
evaluated delayed time to TB diagnosis as a risk factor for transmission of Mycobacterium 
tuberculosis from US-born African-American and White TB cases to their contacts.
STUDY POPULATION AND METHODS
The Tuberculosis Epidemiologic Studies Consortium (TBESC) was funded by the Centers 
for Disease Control and Prevention (CDC; Atlanta, GA, USA) to conduct research on TB 
prevention and control at 21 sites across the United States and Canada.7 One study focused 
on the differences in time to diagnosis between African Americans and Whites. This study 
was conducted at seven TBESC sites and three additional collaborating TB programs that 
accounted for 36.8% of TB cases among US-born Blacks and 15.8% of cases among US-
born Whites reported to the CDC’s National Tuberculosis Surveillance System during the 
enrollment period from 16 December 2009 to 31 March 2011 (Table 1). The following 
analysis was conducted on contact investigation data collected for the study.
To be eligible, patients listed on the site’s TB registry had to 1) have a TB diagnosis that met 
CDC case verification criteria,8 2) be US-born; 3) be non-Hispanic; 4) be African American, 
White, or a combination that included either race; 5) be at least 15 years old at the time of 
diagnosis; and 6) be first reported to a local health department as a presumptive TB case 
from 16 August 2009 to 31 December 2010.
The institutional review boards at the CDC and the local institutions approved the study. All 
living participants provided written informed consent.
Data collection on tuberculosis patients
TB patients were interviewed in person about their demographics, behavioral risk factors, 
medical history, TB symptoms and symptom onset dates, and care seeking for TB and other 
conditions. Clinical information was abstracted from health department records and CDC 
Reported Verified Case of Tuberculosis (RVCT) surveillance reports. For eligible persons 
who died before they could be interviewed, study researchers abstracted relevant information 
from death certificates, health department records, and RVCT reports.
Data collection on tuberculosis contacts
TB contacts’ demographics, places and duration of exposure to the TB patient, LTBI and TB 
disease history, and local determination of whether the contact was close, high risk, or high 
priority, were abstracted from health department contact investigation reports; no personal 
identifiers were collected.
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Tuberculous infection in a contact was determined from the results of the tuberculin skin test 
(TST) or either of the commercially available interferon-gamma release assays (IGRAs)—
QuantiFERON® (Cellestis, Carnegie, VIC, Australia) and T-SPOT®.TB (Oxford 
Immunotec, Abingdon, UK)—as recorded in the health department contact investigation 
records. Contacts were defined as having tuberculous infection if they had 1) a positive 
interpretation noted on the first or second IGRA or TST; 2) ≥5 mm induration recorded on 
the first or second TST; or 3) a diagnosis of TB disease. Contacts were defined as not having 
tuberculous infection if they had negative interpretations of their most recent IGRAs or 
TSTs, or <5 mm induration recorded as the most recent TST result. Contacts with positive 
test results were regarded as recently infected with Mycobacterium tuberculosis if they did 
not have a previous positive TB test, LTBI diagnosis, or TB diagnosis.9
TB patients were asked to provide the month and year of symptom onset, and the 15th of the 
month was selected as the day. For those who did not remember or had died before the 
interview, the earliest symptom date in the medical record was used. The date of TB 
diagnosis was defined as the recorded date the patient first received TB medication. In 
preliminary analyses, time from symptom onset to diagnosis was treated as a continuous and 
dichotomous variable with values based on a review of the literature4,10 and the distribution 
of the study data. Two dichotomous variables were used for the final analyses: <2 months vs. 
≥2 months, and <3 months vs. ≥3 months.
Statistical analysis
As outcomes of tuberculous infection in contacts of the same TB patient were unlikely to be 
independent of each other,4,11,12 generalized estimating equations (GEE) were used to 
control for intra-cluster dependence.13 Relative risks (RRs) and 95% confidence intervals 
(CIs) were calculated using adjusted and unadjusted GEE models. All predictor variables 
with a P value of <0.25 in unadjusted analyses were included in the adjusted model. 
Although time to diagnosis did not meet the threshold for inclusion, it was included in the 
model as it was the main exposure variable of interest. Final models were formed using a 
backward elimination strategy and the Z-statistic. Data were analyzed using Statistical 
Analysis Software (SAS, version 9.3; SAS Inc, Cary, NC, USA).
RESULTS
Of 1014 eligible patients, 128 (13%) died before they could be interviewed and 886 (87%) 
were approached for recruitment. A final 601 patients were enrolled, 126 deceased and 475 
living, with a total of 9525 contacts.
Patients were excluded from analysis if 1) no contacts were listed (n = 116); 2) they had an 
unknown site of disease or had no pulmonary, laryngeal, or pleural involvement, as 
transmission from such patients was unlikely (n = 26);14,15 or 3) time to diagnosis could not 
be determined (n = 77) (Figure 1). After exclusion of these patients, 382 patients and 8275 
contacts remained.
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Contacts other than those designated by health departments as close, high priority, or high 
risk (hereafter, referred to as close contacts) were excluded, to focus on those most likely to 
acquire tuberculous infection (n =3895) (Figure 1).15–18 Also excluded were contacts likely 
to have old infections2 (previous positive TB test, LTBI diagnosis, or TB diagnosis, n=545) 
and those with unknown infection status (n = 534).
After these exclusions, 277 patients (46% of total) remained, 33 deceased and 244 living, 
and their 3301 (35% of total) close contacts. Compared to the patients excluded from the 
study, the included patients were younger at TB diagnosis, less likely to have had a previous 
TB diagnosis, less educated, more likely to report drug and alcohol use, more likely to report 
a cough lasting at least 2 weeks in the year before TB diagnosis, to have positive sputum 
smears, and to have pulmonary cavities (Table 2).
The 214 African-American and 63 White TB patients had a median of three close contacts 
(range 1–438). Compared to Whites, African Americans with TB disease were more likely 
to have human immunodeficiency virus (HIV) infection, be less educated, and younger (data 
not shown). The median estimated time to diagnosis was 2 months (range <1 month–237 
months; interquartile range 4 months) (Figure 2). Of the 3301 close contacts included in the 
analysis, 464 (14%) had tuberculous infection; 22 (4.7%) of those infected had TB disease. 
Of the close contacts with TB disease, 19 (86.4%) were African-American, one contact 
(4.6%) was White, and two contacts (9.1%) were of unknown race. Of the 2870 close 
contacts who were negative on their initial TST/IGRA, 1104 (38.5%) did not have a second 
TST/IGRA result available. Sixty-three contacts (2%) who were negative on their initial 
TST/IGRA were positive on their second TST/IGRA. The majority of contacts (89%) were 
tested using TST; 5% of Whites and 3% of African-Americans were tested using IGRAs (P 
< 0.05). Although a large amount of information was missing for contacts for most variables 
(>65%), available data for sex (85% complete) and race (73% complete) showed that the 
majority of close contacts were male (63%) and African American (53%). Infection was 
more common among females than males (16% vs. 12%, P < 0.01), and among African 
Americans than Whites (15% vs. 9%, P < 0.0001). African-American TB patients (81%) 
were more likely than Whites (12%) to have African-American close contacts (P < 0.0001). 
In unadjusted GEE analysis, close contacts were at higher risk of tuberculous infection if 
their index TB patient was African-American, had pulmonary cavities, was sputum smear-
positive, or reported drug use. Close contacts were at lower risk of tuberculous infection if 
their index patient was homeless or had a previous diagnosis of TB (Table 3). Time to 
diagnosis at the 3-month cut-off had a smaller P value (P = 0.44) than the 2-month cut-off (P 
= 0.70), and was therefore included in the adjusted model (Table 4).
In the adjusted model, close contacts of African-American TB patients had twice the risk of 
tuberculous infection as close contacts of White patients. Further analyses were conducted to 
determine the specific differences in factors associated with infectiousness between African-
American and White TB patients. However, models stratified on race did not produce results 
that changed conclusions of the study. Close contacts of sputum smear-positive patients had 
1.6 times the risk of tuberculous infection compared to close contacts of sputum smear-
negative patients (Table 4). The TB patients’ time to diagnosis was not associated with 
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tuberculous infection in their contacts (aRR 1.18, 95%CI 0.86–1.63). Controlling for study 
site in the adjusted model did not change these conclusions (data not shown).
DISCUSSION
The presence of AFB on sputum smear microscopy is a marker of both the severity of TB 
disease and its infectiousness.19 Sputum smear positivity has long been associated with 
increased risk for tuberculous infection in contacts, and our results support other studies that 
found an increased risk of tuberculous infection in contacts exposed to patients with 
advanced TB disease.2,5–7,16,18,20–23
While some studies have found an association between African-American race and TB 
transmission,4,5,21,24–27 others did not.19,28–32 Our study found that close contacts of US-
born non-Hispanic African Americans were twice as likely to have tuberculous infection as 
close contacts of US-born non-Hispanic Whites; African-American patients were also more 
likely than White patients to have African-American close contacts. However, the 
association between race and tuberculous infection may be a reflection of the generally 
higher prevalence of LTBI in the African-American community rather than an indication of 
recent TB transmission. The 2008 National Health and Nutrition Examination Survey 
(NHANES) found that US-born non-Hispanic African Americans had a significantly higher 
prevalence of LTBI than non-Hispanic Whites (5.7% vs. 1.1%).33
Previous studies found that longer time to diagnosis results in TB transmission in the 
community. A Maryland study that included 54 US-born patients and their 310 close 
contacts reported that 40% of close contacts of patients who had a time to diagnosis of ≥90 
days had positive TSTs compared to 24% of contacts with <90 days’ delay (P < 0.01).4 
While our definition of a close, high risk, or high priority contact varied across sites, the 
local health departments in Maryland shared a similar definition of close contact,4 reducing 
the variance of exposure and increasing the power to find an association between time to 
diagnosis and TB transmission. The Maryland study reported more than twice as many 
contacts with tuberculous infection (35%)4 as found in our study (14%), while earlier studies 
reported even higher proportions of close contacts with tuberculous infection (18–
43%).1,2,16,18 The lower proportion of infection in our study may reflect the continuing 
reduction in overall TB rates in the US-born population.34 In addition, our study used 
IGRAs as well as the TST to diagnose infection in contacts, while previous studies relied 
primarily on TST.1,2,4,16,18 Higher specificity has been reported for IGRAs than for the 
TST,35 and may have influenced our study’s tuberculous infection results. Lastly, our study 
had a smaller proportion of patients with delayed diagnosis (47%) than the Maryland study 
(56%).4 The lower proportion of delayed diagnosis in patients, coupled with the lower 
proportion of infection in contacts, may have contributed to our inability to determine time 
to diagnosis as a risk factor for TB transmission.
One possible limitation of our study is that over one third of the contacts had a negative 
result on their initial TSTor IGRA, and a second TSTor IGRA result was unavailable. Some 
of these contacts could thus have been misclassified as negative, as they might have been 
tested before their immune systems mounted a reaction to tuberculous infection. However, 
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our data show that only a small percentage of contacts (2%) who had negative results on the 
initial TSTor IGRA had positive results on their second test. The effect of misclassification 
on our study results was therefore probably minimal.
Differences in testing methods by race could also have caused systematic bias. However, the 
great majority of contacts (89%) were tested using TST, and the difference in proportions of 
White contacts tested with IGRAs (5%) compared to African Americans (3%), while 
statistically significant, was small. An analysis that excluded contacts who received IGRAs 
did not change the study conclusions.
The study excluded a large number of patients (54%) and their contacts (65%) from the 
analysis. However, 36% of those who were excluded had no contacts listed, and 69% of the 
eliminated contacts were not close, high priority, or high risk. We therefore do not believe 
inclusion of these patients and contacts would have changed our study results.
Despite these limitations, a major strength of our study is that the study population included 
a large number of patients and their contacts from diverse jurisdictions, which supports both 
its reliability and generalizability.
CONCLUSIONS
Our large, multisite study found African American race and sputum smear positivity to be 
independent risk factors for M. tuberculosis infection in close contacts. Sputum smear 
positivity has long been incorporated into contact investigation screening algorithms, and 
our results support the findings of higher LTBI prevalence in US-born African Americans 
observed in previous publications. The lower proportion of infection in our study may 
correspond to the lower overall rates of TB in the US-born population, possibly a reflection 
of the success of the TB program. Similarly, the lower proportion of patients with delayed 
diagnosis may demonstrate the efforts made by clinicians and health departments to reduce 
the time from symptom onset to TB diagnosis and treatment in order to reduce TB disease 
severity and sequelae. The CDC has designated the treatment of LTBI as a major tool in 
achieving the national goal of TB elimination.9 Our study emphasizes the importance of 
contact investigations as a method to find persons with LTBI who could benefit from 
preventive treatment.
Acknowledgments
The authors thank the investigators and staff at all the TB Epidemiologic Studies Consortium (TBESC) 
participating sites from Atlanta, GA (G Albritton, H M Blumberg, M Leonard, J Mack, J Tapia); New York, NY (H 
Anger, P Colson, H Ortega); Research Triangle Park, NC (M Clayton, S Harris, B Levine, Q Xia); Centers for 
Disease Control and Prevention (S Ghosh, G B Grant, E Magee, J Wing); Houston, TX (E A Graviss, P Williams); 
Richmond, VA (S Keller, B Mayes); Dallas, TX (K Kemp, C Lovely); Baltimore, MD (W Cronin, F Maurer, B 
Munk, H Rutz); Nashville, TN (T Chavez-Lindell, J Pinilla, T Stein-Hart, J Warkentin); Newark, NJ (A Sevilla, J 
Vergeon); and Austin, TX (C Wallace).
This research was funded by the Centers for Disease Control and Prevention (CDC), TBESC.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official 
position of the CDC.
Conflicts of interest: none declared.
Pagaoa et al. Page 6














1. Bailey WC, Gerald LB, Kimerling ME, et al. Predictive model to identify positive tuberculosis skin 
test results during contact investigations. JAMA. 2002; 287:996–1002. [PubMed: 11866647] 
2. Gerald LB, Tang S, Bruce F, et al. A decision tree for tuberculosis contact investigation. Am JRespir 
Crit Care Med. 2002; 166:1122–1127. [PubMed: 12379558] 
3. Chin DP, Crane CM, Diul MY, et al. Spread of Mycobacterium tuberculosis in a community 
implementing recommended elements of tuberculosis control. JAMA. 2000; 283:2968–2974. 
[PubMed: 10865275] 
4. Golub JE, Bur S, Cronin WA, et al. Delayed tuberculosis diagnosis and tuberculosis transmission. 
Int J Tuberc Lung Dis. 2006; 10:24–30. [PubMed: 16466033] 
5. Cronin WA, Golub JE, Lathan MJ, et al. Molecular epidemiology of tuberculosis in a low- to 
moderate-incidence state: are contact investigations enough? Emerg Infect Dis. 2002; 8:1271–1279. 
[PubMed: 12453355] 
6. Rodrigo T, Cayla JA, Garcia de Olalla P, et al. Characteristics of tuberculosis patients who generate 
secondary cases. Int J Tuberc Lung Dis. 1997; 1:352–357. [PubMed: 9432392] 
7. Katz D, Albalak R, Wing JS, Combs V. Setting the agenda: a new model for collaborative 
tuberculosis epidemiologic research. Tuberculosis (Edinb). 2007; 87:1–6. [PubMed: 16895763] 
8. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2011. 
Atlanta, GA, USA: US Department of Health and Human Services, CDC; 2012. 
9. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons 
with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers 
Association and CDC. MMWR Recomm Rep. 2005; 54(RR-15):1–47.
10. Riley RL, Moodie AS. Infectivity of patients with pulmonary tuberculosis in inner city homes. Am 
Rev Respir Dis. 1974; 110:810–812. [PubMed: 4429275] 
11. Bosley AR, George G, George M. Outbreak of pulmonary tuberculosis in children. Lancet. 1986; 
1:1141–1143. [PubMed: 2871389] 
12. Packe GE, Patchett PA, Innes JA. Tuberculosis outbreak among Rastafarians in Birmingham. 
Lancet. 1985; 1:627–628. [PubMed: 2857958] 
13. Liang K-Y, Scott LZ. Longitudinal data analysis using generalized linear models. Biometrika. 
1986; 73:13–22.
14. Erkens CG, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in low prevalence 
countries: a European consensus. Eur Respir J. 2010; 36:925–949. [PubMed: 20889463] 
15. Braden CR. Infectiousness of a university student with laryngeal and cavitary tuberculosis. 
Investigative team. Clin Infect Dis. 1995; 21:565–570. [PubMed: 8527545] 
16. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of 
contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000; 
162:2033–2038. [PubMed: 11112109] 
17. Behr MA, Hopewell PC, Paz EA, Kawamura LM, Schecter GF, Small PM. Predictive value of 
contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J 
Respir Crit Care Med. 1998; 158:465–469. [PubMed: 9700122] 
18. Reichler MR, Reves R, Bur S, et al. Evaluation of investigations conducted to detect and prevent 
transmission of tuberculosis. JAMA. 2002; 287:991–995. [PubMed: 11866646] 
19. Carvalho AC, DeRiemer K, Nunes ZB, et al. Transmission of Mycobacterium tuberculosis to 
contacts of HIV-infected tuberculosis patients. Am J Respir Crit Care Med. 2001; 164:2166–2171. 
[PubMed: 11751181] 
20. Aissa K, Madhi F, Ronsin N, et al. Evaluation of a model for efficient screening of tuberculosis 
contact subjects. Am J Respir Crit Care Med. 2008; 177:1041–1047. [PubMed: 18263798] 
21. Ellis BA, Crawford JT, Braden CR, McNabb SJ, Moore M, Kammerer S. Molecular epidemiology 
of tuberculosis in a sentinel surveillance population. Emerg Infect Dis. 2002; 8:1197–1209. 
[PubMed: 12453343] 
Pagaoa et al. Page 7













22. Driver CR, Balcewicz-Sablinska MK, Kim Z, Scholten J, Munsiff SS. Contact investigations in 
congregate settings, New York City. Int J Tuberc Lung Dis. 2003; 7(Suppl 3):S432–S438. 
[PubMed: 14677834] 
23. Gessner BD, Weiss NS, Nolan CM. Risk factors for pediatric tuberculosis infection and disease 
after household exposure to adult index cases in Alaska. J Pediatr. 1998; 132(3 Pt 1):509–513. 
[PubMed: 9544910] 
24. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A 
population-based study using conventional and molecular methods. N Engl J Med. 1994; 
330:1703–1709. [PubMed: 7910661] 
25. Talarico S, Ijaz K, Zhang X, et al. Identification of factors for tuberculosis transmission via an 
integrated multidisciplinary approach. Tuberculosis (Edinb). 2011; 91:244–249. [PubMed: 
21367661] 
26. El Sahly HM, Adams GJ, Soini H, Teeter L, Musser JM, Graviss EA. Epidemiologic differences 
between United States-and foreign-born tuberculosis patients in Houston, Texas. J Infect Dis. 
2001; 183:461–468. [PubMed: 11133378] 
27. Borgdorff MW, Behr MA, Nagelkerke NJ, Hopewell PC, Small PM. Transmission of tuberculosis 
in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis. 2000; 
4:287–294. [PubMed: 10777075] 
28. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York 
City from 1990 to 1999. N Engl J Med. 2002; 346:1453–1458. [PubMed: 12000815] 
29. Bishai WR, Graham NM, Harrington S, et al. Molecular and geographic patterns of tuberculosis 
transmission after 15 years of directly observed therapy. JAMA. 1998; 280:1679–1684. [PubMed: 
9831999] 
30. Weis SE, Pogoda JM, Yang Z, et al. Transmission dynamics of tuberculosis in Tarrant county, 
Texas. Am J Respir Crit Care Med. 2002; 166:36–42. [PubMed: 12091168] 
31. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City. An analysis 
by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994; 330:1710–
1716. [PubMed: 7993412] 
32. Barnes PF, Yang Z, Preston-Martin S, et al. Patterns of tuberculosis transmission in Central Los 
Angeles. JAMA. 1997; 278:1159–1163. [PubMed: 9326475] 
33. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States 
population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit 
Care Med. 2008; 177:348–355. [PubMed: 17989346] 
34. Alami NN, Yuen CM, Miramontes R, Pratt R, Price SF, Navin TR. Trends in tuberculosis—United 
States, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63:229–233. [PubMed: 24647398] 
35. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using 
interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 
2010. MMWR Recomm Rep. 2010; 59(RR-5):1–25.
Pagaoa et al. Page 8














Selection of TB patients and contacts: included TB patients and contacts are on the right, 
exclusions on the left. TB = tuberculosis; LTBI = latent tuberculous infection.
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Distribution of estimated time to TB diagnosis. TB = tuberculosis.
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Table 1





TBESC site Recruitment area Dates of enrollment n n
Maryland Statewide, District of Columbia*, and 
Virginia (statewide)*
Maryland: December 2009–March 2011; 
District of Columbia: May 2010–March 
2011; Virginia: January 2010–September 
2010
42 417
North Carolina Statewide December 2009–March 2011 56 334
New Jersey Statewide and Philadelphia, Pennsylvania* New Jersey: December 2009–March 2011; 
Philadelphia: September 2010–March 2011
4 12
Georgia Clayton Health District, Cobb/Douglas 
Health District, DeKalb Health District, 
Fulton Health District, Gwinnett/Rockdale 
Health Districts, East Central Health 
District, West Central Health District, and 
North Central Health District
January 2010–March 2011 39 1751
Tennessee Shelby County, Davidson County, Mid- 
Cumberland Region: Stewart County, 
Houston County, Humphreys County, 
Montgomery County, Dickson County, 
Robertson County, Cheathum County, 
Williamson County, Sumner County, 
Truesdale County, Wilson County, and 
Rutherford County
Shelby County, Davidson County: 
December 2009–March 2011; Mid-
Cumberland Region: December 2010–
March 2011
37 257
New York Texas New York City December 2009–March 2011 30 147
City of Houston, and Dallas County December 2009–March 2011 69 383
*
District of Columbia and Virginia were sub-contract sites of Maryland; Philadelphia, Pennsylvania was a sub-contract site of New Jersey.
TBESC = Tuberculosis Epidemiologic Studies Consortium; TB = tuberculosis.
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Table 2
Characteristics of TB patients included and excluded in final analysis
TB patients included (n = 277) TB patients excluded (n = 324)
Characteristics n (column %)* n (column %)* P value†
Race
 African American 214 (77) 243 (75) 0.52
 White 63 (23) 81 (25)
Sex
 Male 184 (66) 224 (69) 0.48
 Female 93 (34) 100 (31)
Age at TB diagnosis, years
 <49 138 (50) 111 (34) 0.0003
 ≥49 138 (50) 213 (66)
 Data missing 1 (0) 0
Highest level of schooling completed
 <High school 107 (39) 112 (35) 0.01
 ≥High school 164 (59) 187 (58)
 Data missing 6 (2) 25 (8)
Homeless
 Yes 42 (15) 52 (16) 0.62
 No 235 (85) 271 (84)
 Data missing 0 1 (0)
Excess alcohol use
 Yes 93 (34) 64 (20) <0.0001
 No 183 (66) 249 (77)
 Data missing 1 (<1) 11 (3)
Drug use
 Yes 99 (36) 69 (21) 0.0003
 No 172 (62) 243 (75)
 Data missing 6 (2) 12 (4)
Intravenous drug use
 Yes 6 (2) 12 (4) 0.43
 No 267 (96) 305 (94)
 Data missing 4 (1) 7 (2)
HIV status
 Positive 50 (18) 67 (21) 0.002
 Negative 214 (77) 217 (67)
 Data missing 13 (5) 40 (12)
Sputum smear status
 Positive 161 (58) 115 (35) <0.0001
 Negative 112 (40) 185 (57)
 Data missing 4 (1) 24 (7)
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TB patients included (n = 277) TB patients excluded (n = 324)
Characteristics n (column %)* n (column %)* P value†
Pulmonary cavities
 Yes 127 (46) 87 (27) <0.0001
 No 141 (51) 186 (57)
 Data missing 9 (3) 51 (16)
Previous diagnosis of TB
 Yes 12 (4) 19 (6) 0.04
 No 261 (94) 289 (89)
 Data missing 4 (1) 16 (5)
Cough in year before TB diagnosis
 Yes 219 (79) 106 (33) <0.0001
 No 49 (18) 155 (48)
 Data missing 9 (3) 63 (19)
*
Column percentages may not add up to 100% due to rounding.
†
χ2 test.
TB = tuberculosis; HIV = human immunodeficiency virus.
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Table 3
Unadjusted association of TB patient characteristics with tuberculous infection in close contacts
TB patients (n = 277) Close contacts with tuberculous 
infection (n = 464)
Close contacts without 
tuberculous infection (n = 2837)
GEE unadjusted
Characteristics n (column %) n (row %) n (row %) P value
Time from symptom onset to diagnosis, months
 ≥2 169 (61) 320 (17) 1546 (83) 0.70
 <2 108 (39) 144 (10) 1291 (90)
Time from symptom onset to diagnosis, months
 ≥3 129 (47) 278 (19) 1176 (81) 0.44
 <3 148 (53) 186 (10) 1661 (90)
Race
 African American 214 (77) 431 (15) 2491 (85) 0.01
 White 63 (23) 33 (9) 346 (91)
Sex
 Male 184 (66) 357 (14) 2271 (86) 0.62
 Female 93 (34) 107 (16) 566 (84)
Age at TB diagnosis, years
 <49 138 (50) 352 (14) 2098 (86) 0.39
 ≥49 138 (50) 112 (13) 736 (87)
Highest level of schooling completed
 <High school 107 (39) 221 (12) 1674 (88) 0.77
 ≥High school 164 (59) 242 (17) 1143 (83)
Homeless
 Yes 42 (15) 114 (18) 517 (82) 0.20
 No 235 (85) 350 (13) 2320 (87)
Excess alcohol use
 Yes 93 (33) 205 (15) 1128 (85) 0.99
 No 183 (66) 258 (13) 1702 (87)
Drug use
 Yes 99 (36) 231 (12) 1670 (88) 0.22
 No 172 (62) 227 (17) 1138 (83)
Intravenous drug use
 Yes 6 (2) 1 (5) 19 (95) 0.26
 No 267 (96) 461 (14) 2808 (86)
HIV status
 Positive 50 (18) 75 (11) 632 (89) 0.95
 Negative 214 (77) 385 (15) 2161 (85)
Sputum smear status
 Positive 161 (58) 353 (16) 1849 (84) 0.03
 Negative 112 (40) 111 (10) 982 (90)
Pulmonary cavities
 Yes 127 (46) 309 (16) 1610 (84) 0.03
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TB patients (n = 277) Close contacts with tuberculous 
infection (n = 464)
Close contacts without 
tuberculous infection (n = 2837)
GEE unadjusted
Characteristics n (column %) n (row %) n (row %) P value
 No 141 (51) 145 (11) 1155 (89)
Previous diagnosis of TB
 Yes 12 (4) 3 (6) 51 (94) 0.14
 No 261 (94) 460 (14) 2761 (86)
Cough in year before TB diagnosis
 Yes 219 (79) 395 (15) 2209 (85) 0.29
 No 49 (18) 65 (10) 609 (90)
TB = tuberculosis; GEE = generalized estimating equations; HIV = human immunodeficiency virus.
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Table 4
TB patient characteristics in unadjusted and adjusted GEE model that describe tuberculous infection among 
close contacts
Characteristics GEE unadjusted RR (95%CI) P value GEE adjusted RR (95%CI) P value
Time from symptom onset to diagnosis, months
 ≥3 1.14 (0.82–1.58) 0.44 1.18 (0.86–1.63) 0.31
 <3 Referent Referent
Race
 African American 1.98 (1.20–3.27) 0.01 2.09 (1.27–3.43) 0.004
 White Referent Referent
Homeless
 Yes 0.73 (0.46–1.18) 0.20
 No Referent
Drug use
 Yes 1.24 (0.88–1.73) 0.22
 No Referent
Sputum smear status
 Positive 1.50 (1.05–2.18) 0.03 1.58 (1.10–2.27) 0.01
 Negative Referent Referent
Pulmonary cavities
 Yes 1.44 (1.03–2.02) 0.03
 No Referent
Previous diagnosis of TB
 Yes 0.41 (0.13–1.34) 0.14
 No Referent
TB = tuberculosis; GEE = generalized estimating equations; RR = risk ratio; CI = confidence interval.
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